ahlam1399
07-27-2016, 05:34 PM
TauRx Alzheimer?s drug fails in large study; some benefit seen
CHICAGO (Reuters) - TauRx Pharmaceuticals' experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's disease, a large, late-stage study showed.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=k3XA5lIfTq8:P_ec_Ftnf4U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=k3XA5lIfTq8:P_ec_Ftnf4U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/k3XA5lIfTq8
CHICAGO (Reuters) - TauRx Pharmaceuticals' experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's disease, a large, late-stage study showed.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=k3XA5lIfTq8:P_ec_Ftnf4U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=k3XA5lIfTq8:P_ec_Ftnf4U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=k3XA5lIfTq8:P_ec_Ftnf4U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/k3XA5lIfTq8